Toshiyuki Ishibashi Selected Research

Toshiyuki Ishibashi Research Topics

Disease

5	Atherosclerosis 01/2019 - 06/2002
4	Inflammation (Inflammations) 01/2014 - 06/2007
4	Spasm (Spasms) 02/2010 - 05/2004
4	Coronary Vasospasm (Coronary Artery Vasospasm) 09/2009 - 05/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2022 - 07/2002
3	Diabetic Angiopathies (Diabetic Angiopathy) 06/2011 - 06/2010
2	Myocardial Infarction 01/2019 - 01/2009
2	Ischemia 01/2014 - 10/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 03/2007
2	Ventricular Tachycardia 02/2008 - 03/2007
1	Heart Failure 12/2021
1	Hyperuricemia 12/2021
1	Hypertension (High Blood Pressure) 02/2021
1	Dyslipidemias (Dyslipidemia) 02/2021
1	Xanthomatosis (Xanthoma) 02/2021
1	Coronary Disease (Coronary Heart Disease) 02/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2021
1	Vascular Remodeling 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Acute Coronary Syndrome 01/2014
1	Thrombosis (Thrombus) 01/2014
1	Angina Pectoris 01/2014
1	Hypercholesterolemia 01/2011
1	Stroke (Strokes) 01/2011
1	Type 2 Diabetes Mellitus (MODY) 06/2010
1	Amyloidosis 02/2008
1	Diastolic Heart Failure 02/2008
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2007
1	Coronary Occlusion 12/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2006
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 06/2003
1	Neointima 10/2002

Drug/Important Bio-Agent (IBA)

4	oxidized low density lipoproteinIBA 02/2021 - 01/2011
4	Advanced Glycation End ProductsIBA 01/2019 - 06/2010
3	Thromboplastin (Tissue Factor)IBA 01/2019 - 07/2002
3	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2014 - 10/2009
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 01/2011
3	Serotonin (5 Hydroxytryptamine)IBA 03/2007 - 05/2004
2	Probucol (Lorelco)FDA Link 06/2022 - 02/2021
2	AntioxidantsIBA 02/2021 - 03/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2011 - 06/2010
2	C-Reactive ProteinIBA 01/2011 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011 - 01/2011
2	CholesterolIBA 01/2011 - 01/2011
2	Endothelin-1 (Endothelin 1)IBA 02/2010 - 09/2009
1	Allopurinol (Remid)FDA LinkGeneric 12/2021
1	Uric Acid (Urate)IBA 12/2021
1	Febuxostat FDA Link 12/2021
1	LipidsIBA 02/2021
1	LDL CholesterolIBA 02/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2021
1	HDL CholesterolIBA 02/2021
1	HDL LipoproteinsIBA 02/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	3-nitrotyrosineIBA 01/2019
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2014
1	LectinsIBA 01/2014
1	Technetium (Technetium 99m)IBA 01/2014
1	Ezetimibe (Zetia)FDA Link 01/2011
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2011
1	Coloring Agents (Dyes)IBA 01/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2010
1	Adenosine (Adenocard)FDA LinkGeneric 10/2010
1	Adenosine Diphosphate (ADP)IBA 10/2010
1	AngiotensinsIBA 10/2010
1	Matrix Metalloproteinases (MMPs)IBA 06/2010
1	Endothelins (Endothelin)IBA 02/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009
1	Nonidet P-40IBA 01/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2007
1	CCR2 ReceptorsIBA 06/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2007
1	Glutathione (Reduced Glutathione)IBA 03/2007
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2007
1	SaltsIBA 03/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2007
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2006
1	Propranolol (Inderal)FDA LinkGeneric 11/2006
1	Metoprolol (Toprol-XL)FDA LinkGeneric 11/2006
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2004
1	Platelet Membrane GlycoproteinsIBA 06/2003
1	Protein Sorting Signals (Signal Peptide)IBA 06/2003
1	Angiotensin IIIBA 10/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2002
1	Losartan (Cozaar)FDA LinkGeneric 10/2002
1	Arginine (L-Arginine)FDA Link 10/2002
1	Enalapril FDA LinkGeneric 10/2002
1	rho-Associated KinasesIBA 07/2002
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2002

Therapy/Procedure

4	Therapeutics 12/2021 - 03/2007
1	Secondary Prevention 02/2021
1	Percutaneous Coronary Intervention 01/2014
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2014
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2008
1	Defibrillators (Defibrillator) 02/2008
1	Stem Cell Transplantation 03/2006